Correlates of SGLT-2-inhibitiors use among patients with atherosclerotic cardiovascular disease and type 2 diabetes mellitus: Insights from the department of veterans affairs

被引：4
作者：
Al Rifai, Mahmoud [1 ]
Mahtta, Dhruv [1 ,2 ]
Ramsey, David J. [2 ]
Lee, Michelle T. [1 ,2 ]
Krittanawong, Chayakrit [1 ]
Navaneethan, Sankar D. [3 ,4 ]
Gregg, L. Parker [5 ]
Petersen, Laura A. [1 ,6 ]
Virani, Salim S. [1 ,2 ,7 ,8 ]
机构：
[1] Baylor Coll Med, Dept Med, Sect Cardiol, Houston, TX 77030 USA
[2] Michael E DeBakey VA Med Ctr, Hlth Policy Qual & Informat Program, Hlth Serv Res & Dev Ctr Innovat Qual Effectivenes, Houston, TX 77030 USA
[3] Baylor Coll Med, Sect Nephrol, Houston, TX 77030 USA
[4] Michael E DeBakey VA Med Ctr, Houston, TX USA
[5] Baylor Coll Med, Dept Med, Sect Nephrol, Houston, TX 77030 USA
[6] Baylor Coll Med, Sect Hlth Serv Res, Houston, TX 77030 USA
[7] Baylor Coll Med, Dept Med, Sect Cardiovasc Res, Houston, TX 77030 USA
[8] Michael E DeBakey VA Med Ctr, Sect Cardiol, Houston, TX 77030 USA
来源：
AMERICAN HEART JOURNAL | 2022年 / 248卷
关键词：
D O I：
10.1016/j.ahj.2021.12.006
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
This study using data from the Veterans Affairs (VA) administrative and clinical dataset examined determinants of sodium-glucose cotransporter-2 inhibitors (SGLT-2i) use among patients with concomitant atherosclerotic cardiovascular disease (AS-CVD) and diabetes mellitus. The aim of the present analysis was to identify barriers and facilitators associated with SGLT-2i in a real-world contemporary patient population in order to improve utilization of these guideline-directed agents.
引用
收藏
页码：160 / 162
页数：3
相关论文
共 6 条
  • [1] Association of Race/Ethnicity, Gender, and Socioeconomic Status With Sodium-Glucose Cotransporter 2 Inhibitor Use Among Patients With Diabetes in the US
    Eberly, Lauren A.
    Yang, Lin
    Eneanya, Nwamaka D.
    Essien, Utibe
    Julien, Howard
    Nathan, Ashwin S.
    Khatana, Sameed Ahmed M.
    Dayoub, Elias J.
    Fanaroff, Alexander C.
    Giri, Jay
    Groeneveld, Peter W.
    Adusumalli, Srinath
    [J]. JAMA NETWORK OPEN, 2021, 4 (04)
  • [2] Gunawan F, 2019, J ENDOCR SOC, V3, DOI DOI 10.1210/JS.2019-SUN-149
  • [3] Second-Line Therapy for Type 2 Diabetes Management: The Treatment/Benefit Paradox of Cardiovascular and Kidney Comorbidities
    McCoy, Rozalina G.
    Van Houten, Holly K.
    Karaca-Mandic, Pinar
    Ross, Joseph S.
    Montori, Victor M.
    Shah, Nilay D.
    [J]. DIABETES CARE, 2021, 44 (10) : 2302 - 2311
  • [4] Prescriber Patterns of SGLT2i After Expansions of US Food and Drug Administration Labeling
    Vaduganathan, Muthiah
    Sathiyakumar, Vasanth
    Singh, Avinainder
    McCarthy, Cian P.
    Qamar, Arman
    Januzzi, James L., Jr.
    Scirica, Benjamin M.
    Butler, Javed
    Cannon, Christopher P.
    Bhatt, Deepak L.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (25) : 3370 - 3372
  • [5] Heart Disease and Stroke Statistics-2021 Update A Report From the American Heart Association
    Virani, Salim S.
    Alonso, Alvaro
    Aparicio, Hugo J.
    Benjamin, Emelia J.
    Bittencourt, Marcio S.
    Callaway, Clifton W.
    Carson, April P.
    Chamberlain, Alanna M.
    Cheng, Susan
    Delling, Francesca N.
    Elkind, Mitchell S. V.
    Evenson, Kelly R.
    Ferguson, Jane F.
    Gupta, Deepak K.
    Khan, Sadiya S.
    Kissela, Brett M.
    Knutson, Kristen L.
    Lee, Chong D.
    Lewis, Tene T.
    Liu, Junxiu
    Loop, Matthew Shane
    Lutsey, Pamela L.
    Ma, Jun
    Mackey, Jason
    Martin, Seth S.
    Matchar, David B.
    Mussolino, Michael E.
    Navaneethan, Sankar D.
    Perak, Amanda Marma
    Roth, Gregory A.
    Samad, Zainab
    Satou, Gary M.
    Schroeder, Emily B.
    Shah, Svati H.
    Shay, Christina M.
    Stokes, Andrew
    VanWagner, Lisa B.
    Wang, Nae-Yuh
    Tsao, Connie W.
    [J]. CIRCULATION, 2021, 143 (08) : e254 - e743
  • [6] SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
    Zelniker, Thomas A.
    Wiviott, Stephen D.
    Raz, Itamar
    Im, Kyungah
    Goodrich, Erica L.
    Bonaca, Marc P.
    Mosenzon, Ofri
    Kato, Eri T.
    Cahn, Avivit
    Furtado, Remo H. M.
    Bhatt, Deepak L.
    Leiter, Lawrence A.
    McGuire, Darren K.
    Wilding, John P. H.
    Sabatine, Marc S.
    [J]. LANCET, 2019, 393 (10166) : 31 - 39
1